MARITIDE

View On IPO.GOV.UK

Registered

on 30 Oct 2024

Last Applicant/ Owned by

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States of America

, ,

Serial Number

UK00004118408 filed on 30^th Oct 2024

Registration Number

UK00004118408 registered on
24^th Jan 2025

Correspondent Information

Venner Shipley LLP

200 Aldersgate

London,

EC1A 4HD

MARITIDE

pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders, and obesity; pharmaceut Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders, and obesity; Pharmaceutical preparations for weight reduction and long-term weight loss maintenance.

Mark Details

Serial Number

UK00004118408

Mark Type

Word

Kind of mark

Individual

MARITIDE

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products